TMO
Thermo Fisher Scientific Inc. (TMO)
Last Price$523.6(1.0%)
Market Cap$201.0B
$42.9B
+0.1% YoY
$6,336.0M
+5.7% YoY
$25.7B
Net Debt to FCF - 3.5x
$7,267.0M
16.9% margin

TMO Income Statement

TMO Income Statement Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$42.9B (4.6%) YoY
$17.1B (12.2%) YoY
39.9% margin
Cost of revenue
$25.7B 1.3% YoY
Operating income
$6,859.0M (18.3%) YoY
16.0% margin
Other: $65.0M
Net interest: $496.0M
Operating expenses
$10.3B (6.7%) YoY
Pre-tax income
$6,298.0M (19.6%) YoY
14.7% margin
Net income
$5,995.0M (13.7%) YoY
14.0% margin
Income tax
$284.0M
4.5% tax rate
R&D
$1,337.0M (9.1%) YoY
3.1% of revenue
SG&A
$8,445.0M 18.5% YoY
19.7% of revenue

TMO Income statement key metrics

Annual
Quarterly
LTM

Revenue

$42.9B -4.6% YoY

Operating Income

$6.9B -18.3% YoY

Net Income

$6.0B -13.7% YoY

TMO Balance Sheet

TMO Balance Sheet Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$98.7B
Current assets ($24.6B, 24.9% of total)
$8,077.0M (8.2%)
$9,664.0M (9.8%)
Other current assets
$6,848.0M (6.9%)
Non-current assets ($74.1B, 75.1% of total)
$16.7B (16.9%)
Other non-current assets
$48.0B (48.6%)
Financial position
$26.8B
$8,077.0M$34.9B
Cash & Short-term Investments
Total Debt

TMO Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$98.7B +1.6% YoY

Liabilities

$51.9B -2.1% YoY

Shareholder's Equity

$46.8B +6.1% YoY

TMO Cash Flow Statement

TMO Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$8,537.0M$8,406.0M($5,142.0M)($3,622.0M)($82.0M)$8,097.0M

TMO Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$8,406.0M -8.2% YoY

Capital Expenditure (CAPEX)

($1,479.0M) -34.1% YoY

Free Cash Flow (FCF)

$6,927.0M +0.2% YoY

TMO Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
% growth
2,206.0
0.0%
2,633.0
19.4%
3,791.6
44.0%
9,746.4
157.1%
10,498.0
7.7%
10,109.7
(3.7%)
10,788.7
6.7%
11,725.9
8.7%
12,509.9
6.7%
13,090.3
4.6%
16,889.6
29.0%
16,965.4
0.4%
18,274.1
7.7%
20,918.0
14.5%
24,358.0
16.4%
25,542.0
4.9%
32,218.0
26.1%
39,211.0
21.7%
44,915.0
14.5%
42,857.0
(4.6%)
Cost of Goods Sold (COGS)1,191.51,438.12,223.65,942.06,291.85,960.36,215.16,737.36,993.07,339.28,970.68,782.79,459.110,961.012,994.013,715.015,713.018,977.025,415.025,744.0
% margin
1,014.5
46.0%
1,194.9
45.4%
1,568.1
41.4%
3,804.4
39.0%
4,206.2
40.1%
4,149.4
41.0%
4,573.6
42.4%
4,988.6
42.5%
5,516.9
44.1%
5,751.1
43.9%
7,919.0
46.9%
8,182.7
48.2%
8,815.0
48.2%
9,957.0
47.6%
11,364.0
46.7%
11,827.0
46.3%
16,505.0
51.2%
20,234.0
51.6%
19,500.0
43.4%
17,113.0
39.9%
Operating Expenses761.1914.61,280.42,787.82,941.43,039.73,248.33,643.03,952.74,063.86,014.25,731.26,176.66,892.07,531.07,646.08,612.010,009.010,993.010,254.0
Research & Development Expenses (R&D)134.7152.8170.2238.7249.1246.1287.2340.6376.4395.5691.1692.3754.8888.0967.01,003.01,181.01,406.01,471.01,337.0
Selling, General & Administrative Expenses (SG&A)626.5761.81,110.22,549.12,692.32,196.62,389.42,654.52,828.72,905.23,991.43,724.14,043.84,410.04,823.04,930.05,764.06,842.07,127.08,445.0
237.5
10.8%
263.5
10.0%
242.0
6.4%
974.4
10.0%
1,229.4
11.7%
1,048.9
10.4%
1,264.9
11.7%
1,245.2
10.6%
1,482.1
11.8%
1,609.6
12.3%
2,503.0
14.8%
2,336.2
13.8%
2,449.2
13.4%
2,968.0
14.2%
3,783.0
15.5%
4,594.0
18.0%
7,794.0
24.2%
10,028.0
25.6%
8,393.0
18.7%
6,859.0
16.0%
Interest Income0.00.00.00.051.716.112.526.925.228.047.730.648.481.0137.0224.065.043.0272.0879.0
Interest Expense0.00.00.00.0151.5118.184.7175.3241.6262.1479.9414.9469.6592.0667.0676.0553.0536.0726.01,375.0
Pre-tax Income259.2285.9209.4881.31,149.6927.11,164.61,126.61,269.41,319.52,087.21,936.42,023.92,429.03,262.04,070.07,225.08,841.07,835.06,298.0
% effective tax rate
40.9
15.8%
87.6
30.6%
43.1
20.6%
101.7
11.5%
160.9
14.0%
75.8
8.2%
131.5
11.3%
107.0
9.5%
11.0
0.9%
40.4
3.1%
191.7
9.2%
(43.9)
(2.3%)
(1.4)
(0.1%)
201.0
8.3%
324.0
9.9%
374.0
9.2%
850.0
11.8%
1,109.0
12.5%
703.0
9.0%
284.0
4.5%
% margin
361.8
16.4%
223.2
8.5%
168.9
4.5%
761.1
7.8%
994.2
9.5%
850.3
8.4%
1,035.6
9.6%
1,329.9
11.3%
1,177.9
9.4%
1,273.3
9.7%
1,894.4
11.2%
1,975.4
11.6%
2,021.8
11.1%
2,225.0
10.6%
2,938.0
12.1%
3,696.0
14.5%
6,375.0
19.8%
7,725.0
19.7%
6,950.0
15.5%
5,995.0
14.0%
EPS2.221.380.861.812.342.062.573.493.243.534.764.965.125.647.319.2416.1019.6117.7315.53
Diluted EPS2.171.360.841.722.252.012.533.463.213.484.714.925.095.597.249.1715.9819.4617.6415.45
% margin
336.3
15.2%
435.9
16.6%
502.1
13.2%
1,777.9
18.2%
2,072.2
19.7%
1,832.5
18.1%
1,912.1
17.7%
2,184.2
18.6%
2,494.7
19.9%
2,581.7
19.7%
4,251.9
25.2%
4,039.5
23.8%
4,251.5
23.3%
5,254.0
25.1%
6,195.0
25.4%
6,463.0
25.3%
10,192.0
31.6%
12,964.0
33.1%
11,941.0
26.6%
11,079.0
25.9%